Weiwei Zhu
NO. 661 Huanghe 2nd Road
Binzhou, China
Binzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to "VV-ECMO-supported management of severe ARDS secondary to melioidosis sepsis: A case report and concise review" [IDCases 44 (2026) e02612].
Journal: IDCases
Published: June 15, 2026
Evaluation of Effectiveness of Atorvastatin in Treating Chronic Subdural Hematoma not Requiring Surgery: A Meta-Analysis of Randomized Controlled Trials.
Journal: Annals of Indian Academy of Neurology
Published: September 13, 2023
Interaction between mitochondrial homeostasis and barrier function in lipopolysaccharide-induced endothelial cell injury.
Journal: International journal of experimental pathology
Published: April 19, 2023
Therapeutic effects on cancer of the active ingredients in rhizoma paridis.
Journal: Frontiers in pharmacology
Published: November 11, 2022
Plasma Endothelial Glycocalyx Components as a Potential Biomarker for Predicting the Development of Disseminated Intravascular Coagulation in Patients With Sepsis.
Journal: Journal of intensive care medicine
Published: August 18, 2020
Prognostic analysis of severe patients with bloodstream infection caused by Enterobacteriaceae bacteria
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: June 13, 2020
Both UFH and NAH alleviate shedding of endothelial glycocalyx and coagulopathy in LPS-induced sepsis.
Journal: Experimental and therapeutic medicine
Published: April 10, 2019
Ginsenoside Rb1 administration attenuates focal cerebral ischemic reperfusion injury through inhibition of HMGB1 and inflammation signals.
Journal: Experimental and therapeutic medicine
Published: August 16, 2017
Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2016
Astilbin alleviates LPS-induced ARDS by suppressing MAPK signaling pathway and protecting pulmonary endothelial glycocalyx.
Journal: International immunopharmacology
Published: October 30, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026